Analysts Issue Forecasts for Bausch Health Companies Inc.’s Q3 2023 Earnings (TSE:BHC)

Bausch Health Companies Inc. (TSE:BHC – Free Report) – Stock analysts at Zacks Research raised their Q3 2023 earnings per share (EPS) estimates for Bausch Health Companies in a research note issued to investors on Monday, September 4th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings of $1.25 per share for the quarter, up from their prior estimate of $1.24. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.25 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q1 2024 earnings at $1.02 EPS, Q2 2025 earnings at $0.91 EPS and FY2025 earnings at $5.59 EPS.

Get Bausch Health Companies alerts:

Bausch Health Companies Trading Up 1.2 %

Shares of TSE BHC opened at C$11.54 on Thursday. The business’s 50 day moving average is C$11.61 and its two-hundred day moving average is C$10.80. The company has a debt-to-equity ratio of 7,583.76, a current ratio of 1.12 and a quick ratio of 0.58. Bausch Health Companies has a 1-year low of C$7.56 and a 1-year high of C$13.81. The stock has a market capitalization of C$4.20 billion, a P/E ratio of -16.97, a PEG ratio of 0.21 and a beta of 0.97.

Bausch Health Companies (TSE:BHC – Get Free Report) last posted its earnings results on Thursday, August 3rd. The company reported C$1.08 EPS for the quarter, topping analysts’ consensus estimates of C$1.00 by C$0.08. Bausch Health Companies had a negative return on equity of 72.14% and a negative net margin of 2.23%. The company had revenue of C$2.91 billion for the quarter, compared to the consensus estimate of C$2.74 billion.

Bausch Health Companies Company Profile

(Get Free Report)

Bausch Health Companies Inc operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

Featured Articles

• Five stocks we like better than Bausch Health Companies
• Bank Stocks – Best Bank Stocks to Invest In
• These 3 Wood Stocks are about to go on Discount
• How to Invest in Growth Stocks
• Same Coin, Different Sides: 2 Observability Stocks Reverse Ways
• Do ETFs Pay Dividends? What You Need to Know
• 3 Stocks Awaiting Winter Winds of Opportunity

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.